Jpmorgan Chase & Co »

Ultragenyx Pharmaceutical In shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Ultragenyx Pharmaceutical In shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Ultragenyx Pharmaceutical In

Tip: Access up to 7 years of quarterly data

All positions including Ultragenyx Pharmaceutical In held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ultragenyx Pharmaceutical In by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $105k 3.5k 30.08
2025-03-31 $1.8M 51k 36.21
2024-12-31 $1.3M 30k 42.07
2024-06-30 $1.4M 35k 41.10
2024-03-31 $1.6M 35k 46.69
2019-06-30 $1.0M 17k 62.04
2019-03-31 $5.3M 77k 69.36
2018-06-30 $2.3M 30k 76.87

More positions owned by Jpmorgan Chase & Co

Nvidia Corporation Common (NVDA)
Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Meta Platforms Common (META)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Broadcom Common (AVGO)
Alphabet Common (GOOG)
Tesla Common (TSLA)
Mastercard Incorporated Common (MA)
Alphabet Common (GOOGL)
Vanguard S&p 500 Etf Fund (VOO)
Ishares Core S&p 500 Etf Fund (IVV)
Oracle Corp Common (ORCL)
Abbvie Common (ABBV)

View all positions for Jpmorgan Chase & Co

Top funds holding Ultragenyx Pharmaceutical In

Silverarc Capital Management
Simplex Trading
Group One Trading
Jpmorgan Chase & Co

View all funds holding Ultragenyx Pharmaceutical In